{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:01:34Z","timestamp":1759730494769},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":7115,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1990,3,4]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold> The present study examined 15 patients previously resistant to conventional antihistamines, in which doxepin at doses in the range of 50\u201375 mg\/day was shown to be effective in treatment of chronic urticaria and without significant adverse side effects. However, some controversy remains about its mechanism of action in this particular disease. The aim of the present study was to examine the muscarinic, H<jats:sub>1<\/jats:sub> and H<jats:sub>2<\/jats:sub> blocking activity of doxepin. The following methods were used: a) gastric acid hypersecretion induced by histamine and carbachol in the pylorus\u2010ligated rat preparation; b) contractile dose\u2010response curves to histamine and carbachol in the guinea pig ileum; c) dimaprit\u2010stimulated guinea pig atrium <jats:italic>in vitro.<\/jats:italic> pA<jats:sub>2<\/jats:sub> values were determined for atropine, mepyramine, cimetidine and doxepin. As regards histamine, doxepin (50 mg\/kg, <jats:italic>po<\/jats:italic>) increased gastric pH and decreased secretion volume, gastric acid concentration and total acid output; with carbachol, doxepin weakly antagonized those values. In the ileum, doxepin competitively antagonized carbachol (pA<jats:sub>2<\/jats:sub> = 7.08) and histamine (pA<jats:sub>2<\/jats:sub> = 9.72); pA<jats:sub>2<\/jats:sub> values for atropine and mepyramine against carbachol and histamine were 9.11 and 8.82, respectively. In the atria, the dose\u2010response curve to dimaprit was also competitively displaced by cimetidine (pA<jats:sub>2<\/jats:sub> = 6.69) and doxepin (pA<jats:sub>2<\/jats:sub> = 6.00). Doxepin displayed a very high affinity for H<jats:sub>1<\/jats:sub> histaminic receptor, being 8\u2010fold more potent than mepyramine. Doxepin showed significant H<jats:sub>2<\/jats:sub> blocking activity which was 5 times less potent than that of cimetidine. Doxepin competitively antagonized carbachol in the guinea pig ileum, and was 107 times less potent than atropine. The combined H<jats:sub>1<\/jats:sub>, H<jats:sub>2<\/jats:sub> and muscarinic blocking activities of doxepin may contribute towards explaining its clinical efficacy in the treatment of chronic urticaria.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1990.tb00482.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T18:37:54Z","timestamp":1251311874000},"page":"147-158","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Mechanism of action of doxepin in the treatment of chronic urticaria"],"prefix":"10.1111","volume":"4","author":[{"given":"A.","family":"Figueiredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CA Fontes","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Poiares\u2010Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1966.tb01674.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/236385a0"},{"key":"e_1_2_1_4_1","first-page":"39.16","volume-title":"Textbook of Pharmacology","author":"Bowman WC","year":"1980"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1969.tb16041.x"},{"key":"e_1_2_1_6_1","first-page":"29","article-title":"Ac\u00e7\u00f5es e efeitos da tritiozina, pinav\u00e9rio, proglumide, oxifenciclimina e cimetidina na hipersecre\u00e7\u00e3o g\u00e1strica provocada por alguns secretagogos","volume":"4","author":"Ribeiro Fontes CA","year":"1983","journal-title":"Coimbra Medica"},{"key":"e_1_2_1_7_1","first-page":"27","article-title":"F\u2010461, 3\u2010Diethylamino\u20102,2\u2010diethypropyl 5\u2010(P\u2010nitrophenyl)\u20102\u2010furoate hydrochloride, a new non\u2010anticholinergic spasmolytic and gastric acid inhibitor","volume":"222","author":"Goldenberg MM","year":"1976","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(86)90232-0"},{"key":"e_1_2_1_9_1","first-page":"89","volume-title":"The Urticarias","author":"Greaves MW","year":"1985"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/269163a0"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(81)90149-4"},{"key":"e_1_2_1_12_1","first-page":"25","volume-title":"Pathogenesis of Skin Disease","author":"Millikan LE","year":"1986"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1981.01650070032018"},{"key":"e_1_2_1_14_1","first-page":"89","volume-title":"The Urticarias","author":"Monroe EW","year":"1985"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30917-3"},{"key":"e_1_2_1_16_1","first-page":"92","article-title":"Characteristics of histamine receptors in the isolated and perfused canine coronary arteries","volume":"290","author":"Nakane T.","year":"1987","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1978.tb01493.x"},{"key":"e_1_2_1_18_1","first-page":"40","article-title":"Antidepressants: a clinical update for medical practitioners","volume":"58","author":"Richardson JW","year":"1984","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_1_19_1","first-page":"669","article-title":"Tricyclic antidepressants and histamine H1 receptors","volume":"54","author":"Richelson E.","year":"1979","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_1_20_1","first-page":"40","article-title":"Antimuscarinic and other receptor blocking properties of antidepressants","volume":"58","author":"Richelson E.","year":"1983","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90248-3"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(82)80002-X"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/287548a0"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1990.tb00482.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1990.tb00482.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T18:16:43Z","timestamp":1697998603000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1990.tb00482.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,3,4]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,3,4]]}},"alternative-id":["10.1111\/j.1472-8206.1990.tb00482.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1990.tb00482.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,3,4]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}